Knockdown reduces the phosphorylation levels of Akt, Erk, JNK, p38 MAPK, and FAK, and may consequently inhibit cell proliferation, migration, and invasion and decrease the survival of 5-FU-treated ESCC cells. Here, AKT1 is linked to esophageal squamous cell carcinoma.